Drug targets for COVID-19 therapeutics: Ongoing global efforts

被引:63
作者
Saxena, Ambrish [1 ]
机构
[1] Indian Inst Technol Tirupati, Tirupati, Andhra Pradesh, India
关键词
Coronavirus; Covid-19; drug discovery; drug repurposing; drug target; SARS-CoV-2; ACUTE-RESPIRATORY-SYNDROME; CORONAVIRUS MERS-COV; SARS-CORONAVIRUS; DISEASE; 2019; ARTIFICIAL-INTELLIGENCE; CLINICAL-FEATURES; APPROVED DRUGS; SPIKE-PROTEIN; OLD DRUGS; IN-VITRO;
D O I
10.1007/s12038-020-00067-w
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The current global pandemic COVID-19 caused by the SARS-CoV-2 virus has already inflicted insurmountable damage both to the human lives and global economy. There is an immediate need for identification of effective drugs to contain the disastrous virus outbreak. Global efforts are already underway at a war footing to identify the best drug combination to address the disease. In this review, an attempt has been made to understand the SARS-CoV-2 life cycle, and based on this information potential druggable targets against SARS-CoV-2 are summarized. Also, the strategies for ongoing and future drug discovery against the SARS-CoV-2 virus are outlined. Given the urgency to find a definitive cure, ongoing drug repurposing efforts being carried out by various organizations are also described. The unprecedented crisis requires extraordinary efforts from the scientific community to effectively address the issue and prevent further loss of human lives and health.
引用
收藏
页数:24
相关论文
共 285 条
  • [1] ABBASI J, 2016, JAMA-J AM MED ASSOC, V316, P1636, DOI DOI 10.1001/JAMA.2016.14757
  • [2] Small-Molecule Antiviral β-D-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance
    Agostini, Maria L.
    Pruijssers, Andrea J.
    Chappell, James D.
    Gribble, Jennifer
    Lu, Xiaotao
    Andres, Erica L.
    Bluemling, Gregory R.
    Lockwood, Mark A.
    Sheahan, Timothy P.
    Sims, Amy C.
    Natchus, Michael G.
    Saindane, Manohar
    Kolykhalov, Alexander A.
    Painter, George R.
    Baric, Ralph S.
    Denison, Mark R.
    [J]. JOURNAL OF VIROLOGY, 2019, 93 (24)
  • [3] Polypharmacology in the Treatment of Chagas Disease
    Aguilera, Elena
    Alvarez, Guzman
    Cerecetto, Hugo
    Gonzalez, Mercedes
    [J]. CURRENT MEDICINAL CHEMISTRY, 2019, 26 (23) : 4476 - 4489
  • [4] Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)
    Ahn, Dae-Gyun
    Shin, Hye-Jin
    Kim, Mi-Hwa
    Lee, Sunhee
    Kim, Hae-Soo
    Myoung, Jinjong
    Kim, Bum-Tae
    Kim, Seong-Jun
    [J]. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2020, 30 (03) : 313 - 324
  • [5] MERS coronavirus outbreak: Implications for emerging viral infections
    Al-Omari, Awad
    Rabaan, Ali A.
    Salih, Samer
    Al-Tawfiq, Jaffar A.
    Memish, Ziad A.
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 93 (03) : 265 - 285
  • [6] The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms
    Alanagreh, Lo'ai
    Alzoughool, Foad
    Atoum, Manar
    [J]. PATHOGENS, 2020, 9 (05):
  • [7] The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies
    Albini, Adriana
    Di Guardo, Giovanni
    Noonan, Douglas McClain
    Lombardo, Michele
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (05) : 759 - 766
  • [8] COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine
    Alexander, Paul Elias
    Debono, Victoria Borg
    Mammen, Manoj J.
    Iorio, Alfonso
    Aryal, Komal
    Deng, Dianna
    Brocard, Eva
    Alhazzani, Waleed
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2020, 123 : 120 - 126
  • [9] A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development
    Alexander, Steve P. H.
    Armstrong, Jane F.
    Davenport, Anthony P.
    Davies, Jamie A.
    Faccenda, Elena
    Harding, Simon D.
    Levi-Schaffer, Francesca
    Maguire, Janet J.
    Pawson, Adam J.
    Southan, Christopher
    Spedding, Michael
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (21) : 4942 - 4966
  • [10] Algaissi A, 2020, METHODS MOL BIOL, V2099, P107, DOI 10.1007/978-1-0716-0211-9_9